Myasthenia gravis, drug-induced

G6_MYASTHENIA_ADVERSE

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 G70.0#

1 out of 7 registries used, show all original rules.

45

diagram downward connector

Check minimum number of events None

45

diagram downward connector

Include endpoints None

45

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

42

diagram downward connector
G6_MYASTHENIA_ADVERSE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 G70

Summary Statistics

Key figures

All Female Male
Number of individuals 42 28 14
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 44.54 38.94 55.72

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: G6_MYASTHENIA_ADVERSE – Myasthenia gravis, drug-induced
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Myasthenia gravis, drug-induced

Endpoint not on priority list, no data to show.